Cite Filings / ATTO / 0001172661-26-003341

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Attovia Therapeutics, Inc. Filed 2026-08-12 Acc 0001172661-26-003341

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-08-13 4 Director bought 585,000 shares at an average $17.58 ($10,285,000)
2026-08-13 4 Former 10% Owner bought 585,000 shares at an average $17.58 ($10,285,000)
2026-08-12 SCHEDULE 13G Statement of Beneficial Ownership
2026-08-11 SCHEDULE 13D Beneficial Ownership Report
2026-08-10 4 10% owner acquired 1,957,138 shares (conversion)
2026-08-10 4 10% owner bought 382,352 shares at $17.00 ($6,499,984)
2026-08-07 4 10% owner bought 600,000 shares at $17.00 ($10,200,000)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…